Identification ofPSMD11as a novel cuproptosis‐ and immune‐related prognostic biomarker promoting lung adenocarcinoma progression

Documenti analoghi

• Clinical relevance of somatic mutations in Chinese lung adenocarcinoma and their prognostic implications for survival
  di: Tongxin Li, et al.
  Pubblicazione: (2024)
• Identification of novel pQTL‐SNPs associated with lung adenocarcinoma risk: A multi‐stage study
  di: Yutong Wu, et al.
  Pubblicazione: (2024)
• RBBP4: A novel diagnostic and prognostic biomarker for non‐small‐cell lung cancer correlated with autophagic cell death
  di: Yajing Zhan, et al.
  Pubblicazione: (2024)
• Guanylate binding protein 5 is an immune‐related biomarker of oral squamous cell carcinoma: A retrospective prognostic study with bioinformatic analysis
  di: Masayo Hasegawa, et al.
  Pubblicazione: (2024)
• CD2AP is a potential prognostic biomarker of renal clear cell carcinoma
  di: Can Chen, et al.
  Pubblicazione: (2024)